Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation

Alexander Kirschenbaum, Xin Hua Liu, Shen Yao, Amanda Leiter, Alice C. Levine

Research output: Contribution to journalArticlepeer-review

42 Scopus citations

Abstract

Prostate cancer (PCa) bone metastases are a major cause of morbidity and mortality. There are no effective therapies for PCa bone metastases that prolong survival. Prostatic acid phosphatase (PAP) is a secretory protein expressed by PCa cells. We demonstrate that PAP is strongly expressed in PCa bone metastases in 7/7 patients, while prostate-specific antigen (PSA) is only weakly expressed. The human PCa cell line VCaP secretes PAP and induces an osteoblastic reaction in bone similar to that seen in human PCa bone metastases. Coculture of MC3T3 mouse preosteoblast cells with VCaP cells induces MC3T3 cell growth and differentiation as measured by alkaline phosphatase secretion, and this effect is inhibited by addition of the PAP-inhibitor, l-tartrate. Taken together, these data indicate that PAP is expressed in PCa bone metastases and may play a causal role in the osteoblastic phase of the disease.

Original languageEnglish
Pages (from-to)64-70
Number of pages7
JournalAnnals of the New York Academy of Sciences
Volume1237
Issue number1
DOIs
StatePublished - Nov 2011

Keywords

  • Bone metastases
  • Osteoblasts
  • Prostate cancer
  • Prostatic acid phosphatase

Fingerprint

Dive into the research topics of 'Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation'. Together they form a unique fingerprint.

Cite this